Mammography Systems Market Overview
The global mammography systems market is projected to witness significant growth during the forecast period owing to the initiatives taken by healthcare organizations to raise awareness about the early detection of breast cancer. In terms of product, the market is categorised into analog, digital and breast tomosynthesis systems. The market is expected to be led by digital mammography systems during the forecast period, owing to their features such as image brightness, size, and contrast, which assist in identifying the precise location and level of cancer in the body. However, the market for breast tomosynthesis systems is expected to grow at the highest rate during the forecast period.
Mammography systems make use of various technological platforms for medical imaging studies. These platforms include 2D mammography, 3D mammography, and combined 2D and 3D mammography. Among these technologies, 2D mammography is expected to continue holding the largest share in the market in the coming years, which can be attributed to the increasing need for better communication and advanced diagnosis of breast-related problems. However, during the forecast period, the combined 2D and 3D mammography technology is projected to grow at the highest rate.
The end users in the mammography systems market include hospitals and ASCs, with hospitals estimated to acquire a larger market share in 2017 and ASCs expected to witness a faster growth in demand during the forecast period, as unlike hospitals, ASCs do not require overnight patient stay and are more suitable for cases requiring only diagnosis.
North America is estimated to be the largest contributor to the global mammography systems market in 2017, owing to the increasing prevalence of breast cancer and early adoption of latest technologies in the region. The U.S. is a larger market for mammography systems because of increasing reimbursement policies for mammography and advancements in the mammography technology. During the forecast period, however, Asia-Pacific is expected to witness the highest growth in the industry. The major factors driving the market growth in the region are growing prevalence of breast cancer, rising disposable income, and increasing government initiatives to encourage breast health screening and healthcare infrastructure improvement.
Mammography Systems Market Dynamics
The key trends observed in the mammography systems industry are the introduction of computer-aided design (CAD) systems for mammography and the shift toward full-field digital mammography and hybrid imaging.
Some of the factors leading to the growth of the mammography systems market are an upsurge in the incidence of breast cancer and other related diseases, growing awareness on the early screening for breast cancer, rising geriatric population, increase in the number of breast imaging procedures, and growing popularity of 3D mammography systems. Additionally, better reimbursement policies, increased government funding for breast cancer research, and technological advancements in healthcare are also contributing to the growth of the industry, providing lucrative opportunities to the key industry players.
Innovations in low-cost mammography equipment and growing healthcare infrastructure in emerging economies provide ample opportunities for the players to grow in the mammography systems market. The advent of combined 2D and 3D systems has also increased growth prospects for the industry.
Mammography Systems Market Competitive Landscape
Product launches by the market players are expected to increase their share in the mammography systems market in the coming years. For instance, in January 2018, FUJIFILM Holdings Corporation launched the EP CORSA 15/32 digital radiography system with high-frequency X-ray generator at the 71st National Conference of the Indian Radiological and Imaging Association (IRIA) and the 17th Asian Oceanian Congress of Radiology at Renaissance Mumbai Convention Centre Hotel, Powai, Mumbai. The system is affordable, has a robust design, and provides high-quality output; it has been designed to suit all radiographic examinations.
In September 2017, Hologic Inc. announced the commercial availability of the SmartCurve breast stabilization system, which delivers a comfortable mammogram without compromising on the image quality, dose, or workflow. The system is available exclusively with Hologic's Genius 3D Mammography exam and has been approved by the United States Food and Drug Administration (USFDA) as superior to the conventional 2D mammography system.
Some of the other key players in the industry are Siemens AG, General Electric Company, Canon Medical Systems ANZ Pty. Limited (Toshiba Medical Systems Corporation), Konica Minolta Inc., Planmed Oy, Koninklijke Philips N.V., Analogic Corporation, Delphinus Medical Technologies Inc., Carestream Health, Aurora Imaging Technology Inc., and Micrima Limited.